cryptocurrency asset Top stories

Reuters survey: the short bet of won is at the highest level since October 20, 2022; Indian Rupee's short bet reached the highest level since November 17, 2022; Investors reduced their short bets on Philippine peso, Indonesian rupiah, Thai baht and Singapore dollar.There are 695 listed companies in Jiangsu Province. According to the latest statistics of Jiangsu Listed Companies Association, there were 695 listed companies in Jiangsu Province by the end of November, including 15 new companies this year. Among the 695 companies, there are 216 main boards of Shanghai Stock Exchange, 110 in science and technology innovation board, 126 main boards of Shenzhen Stock Exchange (including one pure B-share), 196 Growth Enterprise Market and 47 North Stock Exchange. By geographical distribution, the total number of listed companies in Suzhou is far ahead in the province, reaching 219, 124 in Nanjing, 123 in Wuxi and 72 in Changzhou. In terms of A-shares, as of the end of November, there were 694 A-share listed companies in Jiangsu Province with a total market value of 6,745.231 billion yuan, accounting for 12.92% and 7.80% of the corresponding total of A-share listed companies respectively.Reuters survey: the short bet of won is at the highest level since October 20, 2022; Indian Rupee's short bet reached the highest level since November 17, 2022; Investors reduced their short bets on Philippine peso, Indonesian rupiah, Thai baht and Singapore dollar.

In the first ten months, Jiangsu's ship exports exceeded 60%, ranking first in the country. According to Nanjing Customs statistics, from January to October this year, Jiangsu exported 85.84 billion yuan of all kinds of ships, ranking first in the country in terms of export scale, with a year-on-year increase of 63.2%. The exports of three main ship types, namely, tankers, container ships and bulk carriers, increased by 179.5%, 91% and 16.2% respectively.Enterprise IT Expenditure Survey: Google Cloud is expected to be the first choice for 50% of the respondents. Tae Kim, a science and technology columnist, wrote that according to a recent survey, Google Cloud has risen rapidly in the enterprise AI expenditure competition and may become the winner. According to the 2025 CIO survey released by Piper Sandler, 81 CIOs were asked about their budget priorities in different suppliers and technical fields. According to the survey, 87% of CIOs surveyed expect to increase the IT budget in 2025, which is the highest proportion of the survey since 2020. In this survey, the status of Google Cloud has risen significantly, surpassing Microsoft and OpenAI to become the "most strategic" AI supplier, with a support rate of 27%, a significant increase from 15% six months ago. Relatively speaking, Microsoft's support rate dropped from 33% to 24%. When asked which cloud company they plan to use to test or implement AI projects next year, 50% of the respondents chose Google Cloud, making it the top AI infrastructure provider. In addition, Harsh Kumar, a Piper semiconductor analyst, pointed out that these results are also beneficial to Invista, because all cloud companies are the main buyers of AI chips in NVIDIA. Kumar estimates that the entire AI chip market will have more than $500 billion in business opportunities by 2028.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).

The average annual salary of doctors is 690,000, and the fixed income accounts for 70%. On the afternoon of December 10th, National Health Commission held a press conference in Shenzhen around the promotion of Sanming's medical reform experience. Relevant officials in Guangdong, Guangzhou and Shenzhen introduced the local medical reform including centralized procurement, price adjustment and salary reform. In 2012, the Shenzhen Municipal People's Government fully invested in introducing the modern management mode of the University of Hong Kong and established the Shenzhen Hospital of the University of Hong Kong. From the details of space design and department name, we can feel that this hospital is different from ordinary mainland hospitals, and the difference in internal system may be even greater-the average annual salary of doctors in this hospital is 690,000 yuan, which is 4.8 times that of the local social wage, of which the fixed salary accounts for 70% and the performance appraisal is 30%. Generally speaking, performance income accounts for a large part of doctors' income. The reporter interviewed two doctors in tertiary hospitals in Beijing, and their performance pay accounted for about 60-70%, which was significantly higher than the fixed salary. In a set of internal data presented by Xu Xiaoping, secretary of the Party Committee of Shenzhen Hospital of the University of Hong Kong, the salary structure of three well-known 3A hospitals in Beijing, Sichuan and Zhejiang is listed, showing that the proportion of fixed income ranges from 20% to 47%. (Beijing News)The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)South Korea's National Assembly passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". The reporter of the General Station was informed that on the 12th local time, South Korea's National Assembly held a general meeting of parliamentarians and passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". (CCTV News)